27 names are moving together; 67% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| PCG | Pacific Gas & Electric Co. | Utilities | -0.1% | Group member |
| FATN | FatPipe, Inc. | Technology | -0.9% | Group member |
| ATO | Atmos Energy Corporation | Utilities | +0.9% | Group member |
| ENB | Enbridge Inc | Energy | +0.1% | Group member |
| FFIV | F5, Inc. | Technology | -0.0% | Group member |
| NPT | Texxon Holding Limited | Consumer Cyclical | +3.7% | Group member |
| QH | Quhuo Limited - American Deposi | Technology | +9.1% | Group member |
| BTI | British American Tobacco Indus | Consumer Defensive | -1.4% | Group member |
| DXYZ | Destiny Tech100 Inc. | Financial Services | +0.9% | Group member |
| OGS | ONE Gas, Inc. | Utilities | +0.5% | Group member |
| PAVS | Paranovus Entertainment Technol | Consumer Defensive | +0.3% | Group member |
| SNAL | Snail, Inc. | Communication Services | +23.9% | Group member |
| SEIC | SEI Investments Company | Financial Services | +0.9% | Group member |
| BILI | Bilibili Inc. | Communication Services | -0.8% | Group member |
| MDU | MDU Resources Group, Inc. | Utilities | +1.0% | Group member |
| NTAP | NetApp, Inc. | Technology | -1.7% | Group member |
| SBLK | Star Bulk Carriers Corp. | Industrials | +1.9% | Group member |
| CPRX | Catalyst Pharmaceuticals, Inc. | Healthcare | +0.0% | Group member |
| UTI | Universal Technical Institute I | Consumer Defensive | -0.6% | Group member |
| ETR | Entergy Corporation | Utilities | +0.9% | Group member |
| GEVO | Gevo, Inc. | Basic Materials | -0.7% | Group member |
| UGI | UGI Corporation | Utilities | -0.7% | Group member |
| STRC | Strategy Inc - Variable Rate Se | Technology | +2.2% | Group member |
| TAL | TAL Education Group | Consumer Defensive | -0.1% | Group member |
Cohort
27 namesParticipation
67% this sessionObserved history
1 daily buildsFiling coverage
17/27 memberscredit / rates affecting interest expense
“The increase in interest expense was primarily attributable to interest on our royalty sale liability and Loan, partially offset by lower convertible debt interest due to the payback of our 2020 Notes in November 2025.”
ESPR 10-Q
demand / volume
“Federal Government will pay for healthcare drugs and services, which could result in reduced demand for our products or drug candidates or additional pricing pressures.”
ESPR 10-K
product pipeline / R&D affecting expense
“The decrease in research and development expenses was primarily attributable to decreased compensation costs, including bonus, stock compensation and consulting partially offset by increase in costs for ongoing pediatric clinical studies.”
ESPR 10-Q
Regulated Utilities & Tech can stay leader-led if CPRX and the next software names fail to join while ESPR keeps moving.
No high-confidence filing-linked non-members are available for this group yet.
Historical cohort observations are not available yet.